novel treatments for myeloid malignancies, including but not limited to, acute and chronic leukemias. In addition, he is interested in alternative donor transplants for patients without a fully matched donor.
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life
AML stories, AML clinical trials, AML 101 articles and events with AML
Thanks to our HealthTree Community for AML Sponsors: